Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Neurobehavioral Manifestations 1 Carcinoma, Hepatocellular 1

Interventions

Capecitabine 13 Oxaliplatin 10 Radiotherapy 8 Surgical Procedures, Operative 6 Drug Therapy 5 tislelizumab 4 Irinotecan 4 sintilimab 3 Neoadjuvant Therapy 3 Immunotherapy 3 Fluorouracil 3 Endoscopic Mucosal Resection 3 Bevacizumab 3 spartalizumab 2 raltitrexed 2 XELOX 2 Trinitrotoluene 2 Radiation 2 Immune Checkpoint Inhibitors 2 Folfox protocol 2 Cetuximab 2 toripalimab 1 sperm releasing substance 1 saxagliptin 1 s-formylglutathione hydrolase 1 envafolimab 1 disitamab vedotin 1 cemiplimab 1 camrelizumab 1 balstilimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Rectal Neoplasms × Artificial Intelligence × Clear all

NCT07189520 2025-09-24

ONCO-TRACK

Università Politecnica delle Marche

Not yet recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡